Good morning Cujo (or it is where i am),
Just re-read the investor presentation in may and still believe you're being overly pessimistic, and can't understand why.
2013 1Q revenue was $2.8m, up from $2.3m in 2012 4Q and compared with $6.6m through all of 2012..
This to me as a shareholder reads as strong revenue growth.
Moreover, with cash at $8.4m and AOK reporting that operating cash flow is contributing to capex, plus the strong development program, suggests to me they're in or near that sweet spot.
Were they to hook a favorable debt faciility, development could accelerate sharply, and as they say they're way below full field development at snake.
There's no question SP lackluster. I atribute this to macro factors, which are subject to change without notice.
Yes, by all means, bring on the quarterly, but for mine, and i've only been in 2 months, everything looks AOK.
- Forums
- ASX - By Stock
- AOK
- todays trade totalled $73.50
todays trade totalled $73.50, page-29
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AOK (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.833M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $21.46K | 7.155M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 20533665 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 10674288 | 5 |
Last trade - 13.35pm 15/11/2024 (20 minute delay) ? |
Featured News
AOK (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online